Fundamental Analysis
65 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +308.3% | +84.7% | 2 / 3 | -37.6% | +21.11 pp | +10.02 pp | +9.0% | 1.15 | 13.87 | 270 | −37,6% | 31,0 | +389,6% | 13.87 | 12.89 | +7,6% |
| Pts | 12 | 12 | 8 | 0 | 12 | 12 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 14.000 (close price on 2026-10-19)EPS (TTM): 1.009
Financial charts
1.Revenue & growth
VND bn270Q2/26
1.Revenue & growth
VND bn270Q2/26
2.Profit & growth
VND bn31,0Q2/26
3.Profit mix (Penman)
VND bn68,4Q2/26
4.Margins & cost structure
%17.3%Q2/26
5.Returns & cash cycle
% · days7.3%Q2/26
6.Earnings quality & cash
VND bn-74,9Q2/26
7.Asset structure
VND bn1.703Q2/26
8.Funding & debt health
VND bn · times1.703Q2/26
9.Revenue backlog
VND bn11,2Q2/26
10.Valuation
times · %15,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %621Q2/26
Adjusted EPS growth, latest quarter
390%
Average adjusted EPS growth, 3 quarters
112%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q2/26